CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- SC TO-I/A Deal Tender Offer Statement by Issuer
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC TO-I Deal Tender Offer Statement by Issuer
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 8-K Event Exit or restructuring costs · Other events
- DEF 14A Proxy Proxy Statement
Page 23 of 31 · 616 filings